CatalYm
GermanyEntry
2022
Hold
4yr
Status
Active
Who owns CatalYm?
CatalYm is a German Biotech company, currently owned by Jeito Capital since 2022 and 2 other investors.
Hand-verified · updated 2026-05-13
Open JSON · CC-BY
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2020 · present
Bayern KapitalActive
2020 · present(6yr) · Seedfonds Bayern · 1996 · VC
coparionActive
2020 · present(6yr) · coparion · 2016 · VC
Jeito CapitalActive
2022 · present(4yr) · Jeito I · 2021 · VC
More from Jeito I
Other portfolio companies in the same fund.
France
Switzerland
Spain
US
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns CatalYm?
CatalYm is currently owned by Jeito Capital, Bayern Kapital and 1 other, through Jeito I, since 2022.
When did Jeito Capital and 2 others acquire CatalYm?
Jeito Capital and 2 others acquired CatalYm in 2022.
Who has owned CatalYm over time?
CatalYm has been through 3 private-equity ownership periods: Bayern Kapital · via Seedfonds Bayern · since 2020; coparion · via coparion · since 2020; Jeito Capital · via Jeito I · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue